Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia
100%
Mantle-Cell Lymphoma
82%
PCI 32765
73%
idelalisib
45%
6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo(1,2-a)pyrazin-8-amine
42%
Non-Hodgkin's Lymphoma
40%
Rituximab
29%
B-Lymphocytes
26%
Syk Kinase
25%
B-Cell Lymphoma
25%
Cladribine
24%
TRU 016
23%
Therapeutics
20%
Agammaglobulinaemia Tyrosine Kinase
19%
Survival
19%
obinutuzumab
18%
Phosphatidylinositol 3-Kinase
17%
Neoplasms
15%
Signal Transduction
14%
Progression-Free Survival
14%
BI 836826
13%
4-(3-(2H-1,2,3-triazol-2-yl)phenylamino)-2-(2-aminocyclohexylamino)pyrimidine-5-carboxamide
12%
CPI203
12%
Phosphotransferases
12%
Lymphoma, Large B-Cell, Diffuse
11%
Bortezomib
11%
CPX-351
10%
Acute Myeloid Leukemia
10%
B-Cell Prolymphocytic Leukemia
10%
Safety
9%
Protein-Tyrosine Kinases
9%
Pharmaceutical Preparations
9%
pevonedistat
9%
Lymphoma
9%
Bendamustine Hydrochloride
9%
Vorinostat
8%
venetoclax
8%
Prostatic Neoplasms
8%
Epigenomics
8%
Phospholipase C gamma
8%
Colony-Stimulating Factor Receptors
8%
Recurrence
8%
Central Nervous System
8%
Lenalidomide
7%
Peripheral T-Cell Lymphoma
7%
Methotrexate
7%
Leukemia
7%
Transplants
7%
Lupus Coagulation Inhibitor
7%